Japanese #3 drugmaker Daiichi Sankyo is buying majority control of India's #1 pharma firm...

|By:, SA News Editor

Japanese #3 drugmaker Daiichi Sankyo is buying majority control of India's #1 pharma firm Ranbaxy for up to $4.6B, a 31.4% premium. Keep an eye on Dr. Reddy's (RDY).